Zhao Q - Search Results

1

IMB5036 inhibits human pancreatic cancer growth primarily through activating necroptosis.

Zhao Q, Zheng Y, Lv X, Gong J, Yang L. Zhao Q, et al. Basic Clin Pharmacol Toxicol. 2022 Mar;130(3):375-384. doi: 10.1111/bcpt.13694. Epub 2021 Dec 20. Basic Clin Pharmacol Toxicol. 2022. PMID: 34841678 Free article.

2

A combinatorial strategy for overcoming primary and acquired resistance of MEK inhibition in colorectal cancer.

Chen J, Dai J, Kang Z, Yang T, Zhao Q, Zheng J, Zhang X, Zhang J, Xu J, Sun G, Yang L, Yang T. Chen J, et al. Among authors: zhao q. Exp Cell Res. 2020 Aug 1;393(1):112060. doi: 10.1016/j.yexcr.2020.112060. Epub 2020 May 11. Exp Cell Res. 2020. PMID: 32407729

3

IMB5036, a novel pyridazinone compound, inhibits hepatocellular carcinoma growth and metastasis.

Lv X, Zhao Q, Dong Y, Yang L, Gong J, Zheng Y, Yang T. Lv X, et al. Among authors: zhao q. Invest New Drugs. 2022 Jun;40(3):487-496. doi: 10.1007/s10637-021-01210-6. Epub 2022 Jan 12. Invest New Drugs. 2022. PMID: 35020067

4

[Programmed Necrosis Inducers for Cancer Treatment].

Zhao Q, Yang LJ, Zheng YB, Gong JH. Zhao Q, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022 Apr;44(2):338-347. doi: 10.3881/j.issn.1000-503X.13241. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2022. PMID: 35538772 Free article. Chinese.

5

OP16, a novel ent-kaurene diterpenoid, potentiates the antitumor effect of rapamycin by inhibiting rapamycin-induced feedback activation of Akt signaling in esophageal squamous cell carcinoma.

Peng KZ, Ke Y, Zhao Q, Tian F, Liu HM, Hou G, Lu Z. Peng KZ, et al. Among authors: zhao q. Biochem Pharmacol. 2017 Sep 15;140:16-27. doi: 10.1016/j.bcp.2017.05.013. Epub 2017 May 21. Biochem Pharmacol. 2017. PMID: 28539264

6

Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer.

Wu S, Zhao Q, Liu S, Kuang J, Zhang J, Onga A, Shen Y, Wang J, Sui H, Ni L, Ye Y, Tu X, Le HB, Zheng Y, Cui R, Zhu W. Wu S, et al. Among authors: zhao q. Int J Oncol. 2024 Aug;65(2):77. doi: 10.3892/ijo.2024.5665. Epub 2024 Jun 14. Int J Oncol. 2024. PMID: 38873997 Free PMC article.

7

CRISPR-Cas9 screening identifies INTS3 as an anti-apoptotic RNA-binding protein and therapeutic target for colorectal cancer.

Wang Z, Zhang C, Guo J, Yang Y, Li P, Wang Z, Liu S, Zhang L, Zeng X, Zhai J, Wang X, Zhao Q, Chen Z, Zhu P, He Q. Wang Z, et al. Among authors: zhao q. iScience. 2024 Apr 6;27(5):109676. doi: 10.1016/j.isci.2024.109676. eCollection 2024 May 17. iScience. 2024. PMID: 38665208 Free PMC article.

8

A20 as a Potential Therapeutic Target for COVID-19.

Wu Y, He L, Li R, Li J, Zhao Q, Shao B. Wu Y, et al. Among authors: zhao q. Immun Inflamm Dis. 2025 Jan;13(1):e70127. doi: 10.1002/iid3.70127. Immun Inflamm Dis. 2025. PMID: 39853876 Review.

9

Selenium-Chondroitin Sulfate Nanoparticles Inhibit Angiogenesis by Regulating the VEGFR2-Mediated PI3K/Akt Pathway.

Zheng X, Liu X, Wang Z, Li R, Zhao Q, Song B, Cheong KL, Chen J, Zhong S. Zheng X, et al. Among authors: zhao q. Mar Drugs. 2025 Jan 2;23(1):22. doi: 10.3390/md23010022. Mar Drugs. 2025. PMID: 39852524

10

Weakly Supervised Nuclei Segmentation with Point-Guided Attention and Self-Supervised Pseudo-Labeling.

Mo Y, Chen L, Zhang L, Zhao Q. Mo Y, et al. Among authors: zhao q. Bioengineering (Basel). 2025 Jan 17;12(1):85. doi: 10.3390/bioengineering12010085. Bioengineering (Basel). 2025. PMID: 39851359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,482 results

Search Page

Filters